Hyperglycaemia increases mortality risk in non‐diabetic patients with COVID‐19 even more than in diabetic patients

Diabetes has been identified as a risk factor for poor outcomes in patients with COVID‐19. We examined the association of hyperglycaemia, both in the presence and absence of pre‐existing diabetes, with severity and outcomes in COVID‐19 patients.

[1]  Mohammad Shafi Kuchay,et al.  New onset diabetes, type 1 diabetes and COVID-19 , 2020, Diabetes & Metabolic Syndrome: Clinical Research & Reviews.

[2]  J. Jacobi,et al.  Maintaining Blood Glucose Levels in Range (70–150 mg/dL) is Difficult in COVID-19 Compared to Non-COVID-19 ICU Patients—A Retrospective Analysis , 2020, Journal of clinical medicine.

[3]  M. Marschollek,et al.  Risk factors for Covid-19 severity and fatality: a structured literature review , 2020, Infection.

[4]  L. Ghiadoni,et al.  Hyperglycemia at Hospital Admission Is Associated With Severity of the Prognosis in Patients Hospitalized for COVID-19: The Pisa COVID-19 Study , 2020, Diabetes Care.

[5]  R. Pop-Busui,et al.  Managing Hyperglycemia in the COVID-19 Inflammatory Storm , 2020, Diabetes.

[6]  S. Del Prato,et al.  COVID-19 in people with diabetes: understanding the reasons for worse outcomes , 2020, The Lancet Diabetes & Endocrinology.

[7]  Zhancheng Gao,et al.  Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19 , 2020, Critical Care.

[8]  Jennifer L. Bell,et al.  Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report , 2020, medRxiv.

[9]  D. Klonoff,et al.  Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States , 2020, Journal of diabetes science and technology.

[10]  Fang Lei,et al.  Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes , 2020, Cell Metabolism.

[11]  C. Mantzoros,et al.  Commentary: COVID-19 in patients with diabetes , 2020, Metabolism.

[12]  15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020 , 2019, Diabetes Care.

[13]  C. Leitão,et al.  Association of multiple glycemic parameters at intensive care unit admission with mortality and clinical outcomes in critically ill patients , 2019, Scientific Reports.

[14]  R. Bellomo,et al.  Dysglycaemia in the critically ill and the interaction of chronic and acute glycaemia with mortality , 2014, Intensive Care Medicine.

[15]  Richard Hellman,et al.  American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[16]  Stephane Heritier,et al.  Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.

[17]  Maria G. Tanzi,et al.  Diabetes care in the hospital , 2019, Practical Diabetes Care for Healthcare Professionals.

[18]  Michael Bailey,et al.  Blood glucose concentration and outcome of critical illness: The impact of diabetes* , 2008, Critical care medicine.

[19]  Daniel J. Johnson,et al.  Influence of individual characteristics on outcome of glycemic control in intensive care unit patients with or without diabetes mellitus. , 2005, Mayo Clinic proceedings.

[20]  R. Schein,et al.  Relationship of baseline glucose homeostasis to hyperglycemia during medical critical illness. , 2004, Chest.

[21]  Sanjoy Ghosh,et al.  Single-dose dexamethasone induces whole-body insulin resistance and alters both cardiac fatty acid and carbohydrate metabolism. , 2004, Diabetes.

[22]  A. Kitabchi,et al.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  H. Chandalia,et al.  STRESS HYPERGLYCAEMIA , 1984, The Lancet.